Marie A. Vodicka
FDA Announces Policy for Unique Nonproprietary Names for Biologics and Biosimilars
Focus on Regulation ·
AbbVie Challenges FDA Biosimilar Labeling
Biosimilars Law Blog ·
FDA Updates U.S. Biosimilar Guidances
Biosimilars Law Blog ·
The First Biosimilar in the U.S. – Five Questions Left Open by FDA
Biosimilars Law Blog ·
FDA Anticipates New Draft Biosimilar Guidances
Biosimilars Law Blog ·